Evidence map›Paper›PMID 37153524›Full record

ArticleFrontiers in chemistry2023

Increased inflammatory cytokines and oxidative stress enhanced antibody production in breast and prostate cancer patients with COVID-19 related depression.

Naif K Binsaleh, Subuhi Sherwani, Reem Eltayeb, Husam Qanash, Abdulrahman S Bazaid, Maryam Althobiti, Mohannad S Hazzazi, Saravanan Rajendrasozhan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Naif K BinsalehDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Ha'il, Ha'il, Saudi Arabia.
Subuhi SherwaniDepartment of Biology, Faculty of Sciences, University of Ha'il, Ha'il, Saudi Arabia.
Reem EltayebDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Ha'il, Ha'il, Saudi Arabia.
Husam QanashDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Ha'il, Ha'il, Saudi Arabia.
Abdulrahman S BazaidDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, University of Ha'il, Ha'il, Saudi Arabia.
Maryam AlthobitiDepartment of Clinical Laboratory Science, College of Applied Medical Science, Shaqra University, Shaqra, Saudi Arabia.
Mohannad S HazzaziDepartment of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
Saravanan RajendrasozhanDepartment of Chemistry, Faculty of Sciences, University of Ha'il, Ha'il, Saudi Arabia.
University of Ha'il · SAKing Abdulaziz University · SAShaqra University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer management is highly dependent on the immune status of the patient. During the COVID-19 pandemic, a large number of people suffered from anxiety and depression, especially cancer patients. The effect of depression on breast cancer (BC) and prostate cancer (PC) patients, during the pandemic has been analyzed in this study. Levels of proinflammatory cytokines (IFN-γ, TNF-α, and IL-6) and oxidative stress markers malondialdehyde (MDA) and carbonyl content (CC) were estimated in patients' serum samples. Serum antibodies against

Indexed as

antibodybreast cancerCOVID-19depressioninflammatory cytokinesoxidative stressprostate cancer

Identifiers

PMID37153524
PMCPMC10157473
OpenAlexW4366729344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.